Apotex asks Supreme Court to overturn Teva ‘Bendeka’ ruling
21-12-2021
Merck Sharp & Dohme fails to secure new nasal spray trial
12-02-2018
Endo sues Lupin over nasal spray
02-08-2017
Sirada Wichitaphornkun / Shutterstock.com
Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro (azelastine) patents.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Bayer Healthcare, Meda Pharmaceuticals, Apotex, allergy treatment, US District Court for the District of Delaware, FDA
